As the elderly population continues to grow exponentially, dry eye disease is becoming increasingly common. In this issue, Sasaki and colleagues identified a NAD+-regulated steroidogenic pathway in the eye that supports the normal function of meibomian glands, and show that increasing the availability of NAD+ can alleviate the dry eye phenotype of aged mice.
Your institute does not have access to this article
Subscribe to Nature+
Get immediate online access to the entire Nature family of 50+ journals
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Lin, J. B. et al. Cell Rep. 17, 69–85 (2016).
Yoshida, M. et al. Cell Metab. 30, 329–342 (2019).
Yoshino, J., Baur, J. A. & Imai, S. I. Cell Metab. 27, 513–528 (2018).
Lin, J. B. & Apte, R. S. Prog. Retin. Eye Res. 67, 118–129 (2018).
Zhang, X. et al. Pharmaceutics 13, 893 (2021).
Cimaglia, G., Votruba, M., Morgan, J. E., André, H. & Williams, P. A. Nutrients 12, 2871 (2020).
Lin, J. B., Tsubota, K. & Apte, R. S. NPJ Aging Mech. Dis. 2, 16003 (2016).
Sasaki, L. et al. Nat. Aging https://doi.org/10.1038/s43587-021-00167-8 (2022).
Golden, M. I. & Meyer, J. J. in StatPearls, https://go.nature.com/3roRI7M (2021).
Sabeti, S., Kheirkhah, A., Yin, J. & Dana, R. Surv. Ophthalmol. 65, 205–217 (2020).
Rubinow, K. B. Mol. Metab. 15, 92–103 (2018).
Mills, K. F. et al. Cell Metab. 24, 795–806 (2016).
Ramsey, K. M. et al. Science 324, 651–654 (2009).
Hägg, S. & Jylhävä, J. eLife 10, e63425 (2021).
Anderson, S. T. & FitzGerald, G. A. Science 369, 1164–1165 (2020).
This work was supported by NIH grant R01 EY019287-08 (R.S.A.), P30 EY02687 (Vision Core Grant), Glenn Foundation for Medical Research Award (R.S.A.), Jeffery T Fort Innovation Fund (R.S.A.), the Starr Foundation (R.S.A.) and an unrestricted grant from Research to Prevent Blindness to the John F Hardesty, MD Department of Ophthalmology and Visual Sciences at Washington University School of Medicine in Saint Louis.
R.S.A. is an inventor on a patent related to NAD+ biology, a cofounder and a member of the clinical and scientific advisory boards of Metro Biotech International. M.Y. is an inventor on a patent related to NAD+/NAMPT biology and receives patent‐licensing fees from Institute for Research on Productive Aging, Japan.
About this article
Cite this article
Yoshida, M., Apte, R.S. NAD+ boosting brings tears to aging eyes. Nat Aging 2, 97–99 (2022). https://doi.org/10.1038/s43587-022-00172-5